Table VII.
Multivariate Cox regression analysis of survival rate in patients with AC.
| 95% confidence interval | ||||||||
|---|---|---|---|---|---|---|---|---|
| Groups | Factors | RC | SE | Wald | P | RR | Lower | Upper |
| Differatiation | Well/moderately/poorly | 1.364 | 0.514 | 7.042 | 0.008 | 3.912 | 1.428 | 10.713 |
| Tumor mass size | ≤3/>3cm | 1.290 | 0.430 | 9.000 | 0.003 | 3.633 | 1.564 | 8.438 |
| Gallstone | No/yes | 0.151 | 0.270 | 0.313 | 0.576 | 1.163 | 0.685 | 1.974 |
| TNM stage | I+II/III/IV | 1.194 | 0.469 | 6.481 | 0.011 | 3.300 | 1.316 | 8.275 |
| Lymph metastasis | No/yes | 1.059 | 0.446 | 5.638 | 0.018 | 2.883 | 1.203 | 6.911 |
| Invasion | No/yes | 1.386 | 0.506 | 7.503 | 0.006 | 3.999 | 1.483 | 10.781 |
| Surgery | Radical/palliative/biopsy | 1.426 | 0.479 | 8.863 | 0.003 | 4.162 | 1.628 | 10.642 |
| MCM2 | −/+ | 0.995 | 0.393 | 6.410 | 0.011 | 2.705 | 1.252 | 5.843 |
| TIP30 | −/+ | −0.857 | 0.374 | 5.251 | 0.022 | 0.424 | 0.204 | 0.883 |
AC, adenocarcinoma; RC, regression coefficients; SE, standard error; RR, relative risk; MCM2, minichromosome maintenance complex component 2; TIP30, HIV-1 tat interactive protein 2.